Replies to post #11821 on GTC Biotherapeutics (fka GTCB)

[Lewis R Goudy]

OK there you go again:

"Past performance of GTC has been a steady decline over it's entire history."

So "same as it ever was", nothing ever changes, H Ford and
JD Rocker took a different view and did ok.

I don't post macro stuff (at least not here) but just this once I make exception:

http://www.telegraph.co.uk/money/main.jhtml?xml=/money/2008/06/18/cnrbs118.xml

What part of "static scoring" don't you understand?

[n4807g]

Ye of little faith. The ink is undoubtedly being applied to the contract(s). This is the promise that we've been given. Of course how long the ink takes to dry has to be factored in.

[vinmantoo]

Lew,

We are in complete agreement. Johnbits problem is that he is looking over the entire history of GTCB as some kind of predictor of what will happen in the near future. That is clearly wrong as he doesn't grasp that rATIII approval in Europe changed the partnership terms or that the soon to be accomplished FDA submission will do the same, though not as much as the upcoming FDA approval.